Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolb

Showing results (71-80 of 279) with videos related to

Pageof 28
Sort By:
The European Respiratory Journal|January 25, 2020
The evolution of the <i>European Respiratory Journal</i>: ready for the new decade!James D Chalmers, Elin L Reeves, Neil J Bullen, et al.
Proceedings of the American Thoracic Society|October 27, 2006
Smad3 signaling involved in pulmonary fibrosis and emphysemaJack Gauldie, Martin Kolb, Kjetil Ask, et al.
Expert Opinion on Emerging Drugs|April 15, 2023
Emerging drugs in the treatment of chronic coughDanica Brister, Mustafaa Wahab, Moaaz Rashad, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2022
Progressive Pulmonary Fibrosis: Putting the Cart Before the HorseKerri A Johannson, Martin Kolb, Jolene H Fisher, et al.
American Journal of Respiratory Cell and Molecular Biology|August 14, 2010
Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungsLaszlo Farkas, Daniela Farkas, Jack Gauldie, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2022
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different DefinitionsYet H Khor, Malik Farooqi, Nathan Hambly, et al.
Scientific Reports|June 14, 2024
Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in miceTina Röpke, Franziska Aschenbrenner, Lars Knudsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesisPhilippe Bonniaud, Peter J Margetts, Kjetil Ask, et al.
The European Respiratory Journal|March 20, 2019
Pulmonary fibrosis: "idiopathic" is not "cryptogenic"Athol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
Expert Opinion on Drug Discovery|May 13, 2020
Current models of pulmonary fibrosis for future drug discovery effortsToyoshi Yanagihara, Sy Giin Chong, Megan Vierhout, et al.
Pageof 28

Showing results (71-80 of 279) with videos related to

Sort By:
Pageof 28
The European Respiratory Journal|January 25, 2020
The evolution of the <i>European Respiratory Journal</i>: ready for the new decade!James D Chalmers, Elin L Reeves, Neil J Bullen, et al.
Proceedings of the American Thoracic Society|October 27, 2006
Smad3 signaling involved in pulmonary fibrosis and emphysemaJack Gauldie, Martin Kolb, Kjetil Ask, et al.
Expert Opinion on Emerging Drugs|April 15, 2023
Emerging drugs in the treatment of chronic coughDanica Brister, Mustafaa Wahab, Moaaz Rashad, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2022
Progressive Pulmonary Fibrosis: Putting the Cart Before the HorseKerri A Johannson, Martin Kolb, Jolene H Fisher, et al.
American Journal of Respiratory Cell and Molecular Biology|August 14, 2010
Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungsLaszlo Farkas, Daniela Farkas, Jack Gauldie, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2022
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different DefinitionsYet H Khor, Malik Farooqi, Nathan Hambly, et al.
Scientific Reports|June 14, 2024
Repetitive invasive lung function maneuvers do not accentuate experimental fibrosis in miceTina Röpke, Franziska Aschenbrenner, Lars Knudsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesisPhilippe Bonniaud, Peter J Margetts, Kjetil Ask, et al.
The European Respiratory Journal|March 20, 2019
Pulmonary fibrosis: "idiopathic" is not "cryptogenic"Athol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
Expert Opinion on Drug Discovery|May 13, 2020
Current models of pulmonary fibrosis for future drug discovery effortsToyoshi Yanagihara, Sy Giin Chong, Megan Vierhout, et al.
Pageof 28